Skip to content

TAK · Takeda Pharmaceutical Co Ltd

Healthcare · +1.1% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 13 feeds behind: Executive-branch trades, 8 days, and 12 more · Every feed →

On this page

The market view

Price chart

The interactive TAK chart (by TradingView) loads here.

Our take

2 rules fired on TAK

In short: none of these rules has solid or some evidence yet, so they show no clear lean on TAK.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for TAK, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on TAK, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of TAK. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 28, 2026–Oct 25, 2026 · UTC dates · today is excluded

Insider purchases

Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored.

Latest 28 days
0
Earlier median
0
Earlier range
0–0
Distinct filers per 28 daysScale: 0–1
Oct 27, 2025Oct 25, 2026
Earlier periodsLatest 28 daysEarlier median 0Limited or missing history

Who appears in the latest period?

No named filers on file for this period.

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Aug 12, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 1. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 20260Partial; excluded
Aug 31, 2026–Sep 27, 20260Within stored history
Sep 28, 2026–Oct 25, 2026Latest period0Partial; excluded
Insider sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: 2; range: 2–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 202613Partial; excluded
Aug 31, 2026–Sep 27, 20262Within stored history
Sep 28, 2026–Oct 25, 2026Latest period0Partial; excluded
Congress purchases · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 2026—Unavailable
Aug 31, 2026–Sep 27, 2026—Unavailable
Sep 28, 2026–Oct 25, 2026Latest period—Unavailable
Congress sales · Source needs an update

The feed’s newest disclosure is too old for a current comparison. Counts show only the records already stored. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 27, 2025–Nov 23, 2025—Unavailable
Nov 24, 2025–Dec 21, 2025—Unavailable
Dec 22, 2025–Jan 18, 2026—Unavailable
Jan 19, 2026–Feb 15, 2026—Unavailable
Feb 16, 2026–Mar 15, 2026—Unavailable
Mar 16, 2026–Apr 12, 2026—Unavailable
Apr 13, 2026–May 10, 2026—Unavailable
May 11, 2026–Jun 7, 2026—Unavailable
Jun 8, 2026–Jul 5, 2026—Unavailable
Jul 6, 2026–Aug 2, 2026—Unavailable
Aug 3, 2026–Aug 30, 2026—Unavailable
Aug 31, 2026–Sep 27, 2026—Unavailable
Sep 28, 2026–Oct 25, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

FDA & trials

Owners & lobbying

All 27 records in this snapshot
  1. Record date
  2. Record date
  3. Record date
  4. Record date
  5. Record date
  6. Disclosed
    Lauren Rusckowski Duprey · Sale

    Transaction dated Sep 14, 2026

  7. Disclosed
    Andrew Stewart Plump · Sale

    Transaction dated Sep 2, 2026

  8. Disclosed
    Andrew Stewart Plump · Sale

    Transaction dated Aug 19, 2026

  9. Disclosed
    Nicola Deidre Petal Greenway · Sale

    Transaction dated Aug 18, 2026

  10. Disclosed
    Agosti Marcello Pignagnoli · Sale

    Transaction dated Aug 10, 2026

  11. Disclosed
    Andrew Stewart Plump · Sale

    Transaction dated Aug 10, 2026

  12. Disclosed
    Awny Samaan Botros Farajallah · Sale

    Transaction dated Aug 10, 2026

  13. Disclosed
    Elaine Mary Shannon · Sale

    Transaction dated Aug 10, 2026

  14. Disclosed
    Elaine Mary Shannon · Sale

    Transaction dated Aug 11, 2026

  15. Disclosed
    Gabriele Ricci · Sale

    Transaction dated Aug 10, 2026

  16. Disclosed
    Giles Richard Platford · Sale

    Transaction dated Aug 10, 2026

  17. Disclosed
    Julie So-Young Kim · Sale

    Transaction dated Aug 10, 2026

  18. Disclosed
    Lauren Rusckowski Duprey · Sale

    Transaction dated Aug 10, 2026

  19. Disclosed
    Natalie Anne Marie Furney · Sale

    Transaction dated Aug 10, 2026

  20. Disclosed
    Nicola Deidre Petal Greenway · Sale

    Transaction dated Aug 10, 2026

  21. Disclosed
    Nicola Deidre Petal Greenway · Sale

    Transaction dated Aug 10, 2026

  22. Disclosed
    Nicola Deidre Petal Greenway · Sale

    Transaction dated Aug 10, 2026

  23. Disclosed
    Ramy Riad Ahmed Ibrahim · Sale

    Transaction dated Aug 10, 2026

  24. Disclosed
    Rhonda Janice Pacheco · Sale

    Transaction dated Aug 10, 2026

  25. Disclosed
    Teresa Marie Bitetti · Sale

    Transaction dated Aug 10, 2026

  26. Record date
  27. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on TAK disclosed in the last 90 days.

See every Congress trade on TAK →

Company insiders

0 buys · 17 sells (20 filed lots) · $13.1M sold

  1. ▼ SELLLauren Rusckowski Duprey Chief Transformation OfficerTAK Takeda Pharmaceutical Co Ltd$640Kdisclosed Sep 15 · filed 1 day after the trade
  2. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$2.1Mdisclosed Sep 3 · filed 1 day after the trade
  3. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$363Kdisclosed Aug 21 · filed 2 days after the trade
  4. ▼ SELLNicola Deidre Petal Greenway Chief Human Resources OfficerTAK Takeda Pharmaceutical Co Ltd$235Kdisclosed Aug 19 · filed 1 day after the trade
  5. ▼ SELLElaine Mary Shannon Pres., Global Supply & QualityTAK Takeda Pharmaceutical Co Ltd$68Kdisclosed Aug 12 · filed 2 days after the trade
  6. ▼ SELLAwny Samaan Botros Farajallah Chief Medical OfficerTAK Takeda Pharmaceutical Co Ltd$240Kdisclosed Aug 12 · filed 2 days after the trade
  7. ▼ SELLAgosti Marcello Pignagnoli Head, Strat. & Port. DevTAK Takeda Pharmaceutical Co Ltd$393Kdisclosed Aug 12 · filed 2 days after the trade
  8. ▼ SELLTeresa Marie Bitetti President, OBUTAK Takeda Pharmaceutical Co Ltd$855Kdisclosed Aug 12 · filed 2 days after the trade
  9. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$2.8Mdisclosed Aug 12 · filed 2 days after the trade
  10. ▼ SELLGabriele Ricci Chief Data & Tech. OfficerTAK Takeda Pharmaceutical Co Ltd$429Kdisclosed Aug 12 · filed 2 days after the trade
See every insider trade on TAK →

Filings & events

Filing red flags 43

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

Lobbying 53

Lobbying reports filed with the Senate for the company.

$9.4M across 53 reports

Issues named in the most reports

  • Health Issues 29
  • Medicare/Medicaid 29
  • Taxation/Internal Revenue Code 23
  • Trade (domestic/foreign) 18
  • Pharmacy 12
Biggest named funds (13F)

The largest TAK holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on TAK

  1. ▼ SELLLauren Rusckowski Duprey Chief Transformation OfficerTAK Takeda Pharmaceutical Co Ltd$640Kdisclosed Sep 15 · filed 1 day after the trade
  2. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$2.1Mdisclosed Sep 3 · filed 1 day after the trade
  3. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$363Kdisclosed Aug 21 · filed 2 days after the trade
  4. ▼ SELLNicola Deidre Petal Greenway Chief Human Resources OfficerTAK Takeda Pharmaceutical Co Ltd$235Kdisclosed Aug 19 · filed 1 day after the trade
  5. ▼ SELLElaine Mary Shannon Pres., Global Supply & QualityTAK Takeda Pharmaceutical Co Ltd$68Kdisclosed Aug 12 · filed 2 days after the trade
  6. ▼ SELLAwny Samaan Botros Farajallah Chief Medical OfficerTAK Takeda Pharmaceutical Co Ltd$240Kdisclosed Aug 12 · filed 2 days after the trade
  7. ▼ SELLAgosti Marcello Pignagnoli Head, Strat. & Port. DevTAK Takeda Pharmaceutical Co Ltd$393Kdisclosed Aug 12 · filed 2 days after the trade
  8. ▼ SELLTeresa Marie Bitetti President, OBUTAK Takeda Pharmaceutical Co Ltd$855Kdisclosed Aug 12 · filed 2 days after the trade
  9. ▼ SELLAndrew Stewart Plump President, R&DTAK Takeda Pharmaceutical Co Ltd$2.8Mdisclosed Aug 12 · filed 2 days after the trade
  10. ▼ SELLGabriele Ricci Chief Data & Tech. OfficerTAK Takeda Pharmaceutical Co Ltd$429Kdisclosed Aug 12 · filed 2 days after the trade
  11. ▼ SELLNicola Deidre Petal Greenway Chief Human Resources OfficerTAK Takeda Pharmaceutical Co Ltd$17.1Kdisclosed Aug 12 · filed 2 days after the trade
  12. ▼ SELLGiles Richard Platford President, IBUTAK Takeda Pharmaceutical Co Ltd$532Kdisclosed Aug 12 · filed 2 days after the trade
  13. ▼ SELLNicola Deidre Petal Greenway Chief Human Resources OfficerTAK Takeda Pharmaceutical Co Ltd$116Kdisclosed Aug 12 · filed 2 days after the trade
  14. ▼ SELLRamy Riad Ahmed Ibrahim President, PDT BUTAK Takeda Pharmaceutical Co Ltd$124Kdisclosed Aug 12 · filed 2 days after the trade
  15. ▼ SELLJulie So-Young Kim President and CEOTAK Takeda Pharmaceutical Co Ltd$1.5Mdisclosed Aug 12 · filed 2 days after the trade
  16. ▼ SELLNicola Deidre Petal Greenway Chief Human Resources OfficerTAK Takeda Pharmaceutical Co Ltd$589Kdisclosed Aug 12 · filed 2 days after the trade
  17. ▼ SELLNatalie Anne Marie Furney Global General CounselTAK Takeda Pharmaceutical Co Ltd$528Kdisclosed Aug 12 · filed 2 days after the trade
  18. ▼ SELLElaine Mary Shannon Pres., Global Supply & QualityTAK Takeda Pharmaceutical Co Ltd$357Kdisclosed Aug 12 · filed 1 day after the trade
  19. ▼ SELLRhonda Janice Pacheco President, U.S. Business UnitTAK Takeda Pharmaceutical Co Ltd$289Kdisclosed Aug 12 · filed 2 days after the trade
  20. ▼ SELLLauren Rusckowski Duprey Chief Transformation OfficerTAK Takeda Pharmaceutical Co Ltd$814Kdisclosed Aug 12 · filed 2 days after the trade
See the trades on TAK in the feed →
People & votes

Which members of Congress traded TAK, sponsored bills that touch it and voted on them — opens here.